克服质母细胞瘤免疫疗法耐药性:挑战和新兴策略
Maowu Fu1, Bing Xue2, Xiuming Miao3
1Department of Neurosurgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Frontiers in pharmacology
|April 14, 2025
概括
质母细胞瘤免疫疗法面临着免疫逃避和血脑屏障等挑战. 像高级CAR-T细胞这样的新策略显示出改善质母细胞瘤治疗结果的希望.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有攻击性的原发性脑瘤,尽管采用标准治疗,预后不佳.
- 目前的免疫疗法由于GBM的免疫抑制性瘤微环境 (TME) 和低突变负担而面临抵抗.
研究的目的:
- 审查质母细胞瘤免疫疗法的挑战和新兴策略.
- 要突出免疫逃避,血脑屏障 (BBB) 透和TME作为关键障碍.
主要方法:
- 文献综述侧重于质母细胞瘤免疫疗法.
- 对免疫逃避机制,BBB限制和TME特征的分析.
- 评估当前和新型免疫治疗方法,包括CAR-T细胞.
主要成果:
- 免疫检查点抑制剂和CAR-T细胞在临床环境中的临床前成功是有限的.
- 抗原异质性,免疫细胞枯竭和BBB阻碍了有效的免疫疗法.
- 像双重准CAR-T细胞和先进的传递系统这样的新兴策略显示出潜力.
结论:
- 克服质母细胞瘤独特的免疫挑战对于治疗进步至关重要.
- 需要新的方法来增强整个BBB的免疫细胞贩运和疗效.
- 对工程免疫细胞和传递系统的进一步研究可能会改善患者的治疗结果.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.3K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.8K
相关概念视频
01:27Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K